The CMO/CDMO market is experiencing a significant paradigm shift characterized by robust growth, underpinned by a projected compound annual growth rate (CAGR) of 5.90%. With the market size anticipated to expand from USD 27.08 billion in 2024 to USD 50.89 billion by 2035, stakeholders are focusing on optimizing operations through strategic outsourcing. As pharmaceutical companies increasingly...